Black Diamond Therapeutics (BDTX) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for Black Diamond Therapeutics (BDTX) over the last 7 years, with Dec 2024 value amounting to $343,000.

  • Black Diamond Therapeutics' Depreciation and Depletion rose 720.00% to $123,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $205,000, marking a year-over-year increase of 294.23%. This contributed to the annual value of $343,000 for FY2024, which is 21.51% down from last year.
  • Per Black Diamond Therapeutics' latest filing, its Depreciation and Depletion stood at $343,000 for FY2024, which was down 21.51% from $437,000 recorded in FY2023.
  • In the past 5 years, Black Diamond Therapeutics' Depreciation and Depletion ranged from a high of $508,000 in FY2022 and a low of $52,000 during FY2020.
  • For the 3-year period, Black Diamond Therapeutics' Depreciation and Depletion averaged around $429,333, with its median value being $437,000 (2023).
  • Per our database at Business Quant, Black Diamond Therapeutics' Depreciation and Depletion skyrocketed by 294.23% in 2021 and then declined by 21.51% in 2024.
  • Yearly analysis of 5 years shows Black Diamond Therapeutics' Depreciation and Depletion stood at $52,000 in 2020, then skyrocketed by 294.23% to $205,000 in 2021, then soared by 147.80% to $508,000 in 2022, then dropped by 13.98% to $437,000 in 2023, then fell by 21.51% to $343,000 in 2024.